Comparison of the sputum microbiome between patients with stable nontuberculous mycobacterial pulmonary disease and patients requiring treatment
Open Access
- 18 May 2024
- journal article
- research article
- Published by Springer Nature in BMC Microbiology
- Vol. 24 (1) , 1-9
Abstract
Background: We evaluated whether the sputum bacterial microbiome differs between nontuberculous mycobacteria pulmonary disease (NTM-PD) patients with stable disease not requiring antibiotic treatment and those requiring antibiotics. Methods: We collected sputum samples from 21 clinically stable NTM-PD patients (stable group) and 14 NTM-PD patients needing antibiotic treatment (treatment group). We also obtained 13 follow-up samples from the stable group. We analyzed the 48 samples using 16S rRNA gene sequencing (V3–V4 region) and compared the groups. Results: In the linear discriminant analysis effect size (LEfSe) analysis, the species Porphyromonas pasteri, Haemophilus parahaemolyticus, Prevotella nanceiensis, and Gemella haemolysans were significantly more prevalent in the sputum of the stable group compared to the treatment group. No taxa showed significant differences in alpha-/beta-diversity or LEfSe between the 21 baseline and 13 follow-up sputum samples in the stable group. In the stable group, the genus Bergeyella and species Prevotella oris were less common in patients who achieved spontaneous culture conversion (n = 9) compared to those with persistent NTM positivity (n = 12) (effect size 3.04, p = 0.039 for Bergeyella; effect size 3.64, p = 0.033 for P. oris). In the treatment group, H. parainfluenzae was more common in patients with treatment success (n = 7) than in treatment-refractory patients (n = 7) (effect size 4.74, p = 0.013). Conclusions: Our study identified distinct bacterial taxa in the sputum of NTM-PD patients based on disease status. These results suggest the presence of a microbial environment that helps maintain disease stability.Keywords
All Related Versions
Funding Information
- National Research Foundation of Korea (2020R1C1C1008038)
This publication has 33 references indexed in Scilit:
- The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung DiseaseThe Journal of Immunology, 2016
- Possible role of anaerobes in the pathogenesis of nontuberculous mycobacterial infectionRespirology, 2015
- Epidemiology of Human Pulmonary Infection with Nontuberculous MycobacteriaClinics in Chest Medicine, 2015
- Chronic obstructive pulmonary disease and asthma‐associated Proteobacteria, but not commensal Prevotella spp., promote Toll‐like receptor 2‐independent lung inflammation and pathologyImmunology, 2015
- Early Respiratory Microbiota Composition Determines Bacterial Succession Patterns and Respiratory Health in ChildrenAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Risk factors for deterioration of nodular bronchiectatic Mycobacterium avium complex lung diseaseThe International Journal of Tuberculosis and Lung Disease, 2014
- Sputum Microbiota in Tuberculosis as Revealed by 16S rRNA PyrosequencingPLOS ONE, 2013
- Patients with Nontuberculous Mycobacterial Lung Disease Exhibit Unique Body and Immune PhenotypesAmerican Journal of Respiratory and Critical Care Medicine, 2013
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Distribution of oral Haemophilus species in dental plaque from a large adult populationInfection and Immunity, 1984